Venture-Backed Startups

BioCell Analytica provides effect-based analysis using cultured cells to detect health- and environment-hazardous contaminants in water, soil, and sediment, capturing the combined "cocktail effect" of multiple substances. It serves the water industry for testing drinking water, wastewater treatment efficiency, and chemical pollution monitoring.

1 investor

Biocellis develops a patented bioluminescence immunoassay platform that delivers laboratory-grade, picogram-level sensitivity with results in under 60 seconds in a compact, portable format for point-of-care and high-throughput screening. Its diagnostics target human health, veterinary, environmental, food safety, and public screening applications across hospitals, clinics, and field settings.</parameter> <parameter name="founders">[{"full_name": "Vincent Poher", "title": "Co-founder", "linkedin_url": "https://www.linkedin.com/in/vincentpoher/"}, {"full_name": "Thierry Rose", "title": "Co-founder", "linkedin_url": "https://www.linkedin.com/in/thierry-rose-122013254/"}, {"full_name": "Sophie Goyard", "title": "Co-founder", "linkedin_url": "https://www.linkedin.com/in/sophie-goyard-968844103/"}]</parameter> <parameter name="hq_city">Grenoble

1 investor

0 investors

0 investors

Bioceptive develops women's health medical devices, including a patented FDA-approved Cervical Suction Retractor that replaces the tenaculum for gynecological procedures and an IUD inserter, offering single-use disposable instruments aimed at reducing pain during transcervical procedures. It serves healthcare professionals in the U.S. and developing regions, and is based in New Orleans, Louisiana.

2 investors

Bioceres Crops develops and commercializes agricultural productivity solutions—including patented seed technologies (such as its HB4 drought-tolerant program), microbial ag-inputs, crop nutrition and protection products, and digital tools for growers. It serves farmers and agricultural stakeholders with technologies aimed at improving crop resilience to climate change and enabling production traceability.

1 investor

0 investors

BioChange develops CellFoam, a biodegradable and biocompatible foam scaffold technology for regenerative medicine that supports tissue repair and organ recovery. Its product lines target dental, aesthetic, and human medical uses as well as veterinary care (including products like ReFoam, Revolette, ReGumVet, VetFoam, and vitaloc), with its veterinary line already in the U.S. market.

1 investor

Biochar Now manufactures biochar at large scale using kiln-based slow pyrolysis technology, serving applications such as specialty agriculture, land reclamation, oil and gas, odor control, bio-filler, and nutrient removal. The company operates in the biochar and carbon materials industry.

0 investors

BioChip Labs provides laboratory testing services for blood disorders, including sickle cell disease and thalassemia, using traditional and proprietary blood cell analysis methods. The company conducts comprehensive biomarker assays and works with clinicians and researchers.

1 investor

1 investor

1 investor

BioClé is a biotechnology company developing a delivery platform based on bacterial extracellular vesicles (bEVs) to improve the stability, bioavailability, and cellular uptake of bioactive compounds.

1 investor

0 investors

BioClinique operates a network of medical laboratories providing clinical testing services across the Île-de-France region in France.

1 investor

Clario provides clinical trial endpoint technologies and solutions—including software, connected devices, and AI across cardiac safety, eCOA, medical imaging, precision motion, and respiratory—for pharmaceutical sponsors, clinical trial sites, and CROs. It supports site-based, hybrid, and decentralized drug trials across more than 100 countries.

1 investor

3 investors

BioCollabs sells plant-based dietary supplements built around clinically-backed, trademarked phytosome ingredients aimed at supporting liver health, digestion, metabolism, and detoxification. Its formulations are marketed to consumers with concerns such as belly fat, fatty liver, cholesterol, and bloating.

3 investors

The BioCollective develops microbiome research tools, including a whole-stool BioCollector Kit, a fecal sample bank, and the Bioflux computational metabolic model used to build and evaluate probiotic consortia. Its products and reference materials serve research institutions, biotherapeutics companies, and probiotic developers, and it also produces the BiotiQuest consumer probiotic brand.

0 investors

Biocom (operated by Allostar Inc.) offers scientific biodata analysis services—such as comprehensive metabolic function testing, food intolerance analysis, and stress/aging assessments—paired with personalized diet, nutrition, sleep, and exercise solutions, health foods, and management challenge programs. It sells these tests, supplements, and membership benefits to consumers through its official online store in South Korea.

1 investor

Biocomposites is a British company that develops and manufactures bone cement products used by surgeons in orthopaedic and surgical procedures. Its SYNICEM line is distributed globally and being expanded to serve UK NHS demand.

1 investor

BioCompute is developing DNA-based data storage technology, offering exclusive pilot programs for early access. The company operates in the data storage and biotechnology space.

1 investor

1 investor

BioConnection is a contract manufacturing organization (CMO) providing aseptic fill & finish services and freeze-drying (lyophilization) for sterile pharmaceutical drug products at clinical and commercial scale. It also offers formulation and analytical development, packaging, tech transfer, and regulatory support to biopharma clients from its EMA- and US-FDA-approved facilities in the Netherlands.

1 investor